Literature DB >> 20619531

Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.

Yong Hwy Kim1, So Won Oh, You Jung Lim, Chul-Kee Park, Se-Hoon Lee, Keon Wook Kang, Hee-Won Jung, Kee Hyun Chang.   

Abstract

PURPOSE: The authors analyzed the characteristics of perfusion magnetic resonance imaging (MRI), (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and (11)C-methionine (MET) PET to compare the efficacies of these modalities in making the distinction between radiation necrosis and tumor recurrence of high-grade glioma. PATIENTS AND METHODS: Ten patients were evaluated with dynamic susceptibility contrast perfusion MRI, (11)C-MET PET and (18)F-FDG PET to visualize gadolinium-enhanced lesions during the post-radiation follow-up period. In the perfusion MRI, four regions of interest (ROIs) were identified and average values were calculated. A reference ROI of the same size was defined in the contralateral white matter to obtain the relative cerebral blood volume (rCBV). After coregistering the PET images with the MRI, we measured the maximum uptake values of the lesion and of the contralateral cerebral white matter as reference area to calculate the L(max)/R(max) ratio.
RESULTS: The rCBV was higher in the recurrence group than in the necrosis group (p=0.010). There was no difference between groups in terms of the L(max)/R(max) ratio as derived from the (18)F-FDG and (11)C-MET PET.
CONCLUSION: A quantitative rCBV as calculated from a perfusion MRI scan might be superior to the L(max)/R(max) ratio as derived from (18)F-FDG and (11)C-MET PET in order to distinguish a recurrence of high-grade glioma from radiation necrosis.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619531     DOI: 10.1016/j.clineuro.2010.06.005

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  54 in total

1.  Comparison of Diffusion Tensor Imaging and Magnetic Resonance Perfusion Imaging in Differentiating Recurrent Brain Neoplasm From Radiation Necrosis.

Authors:  William R Masch; Page I Wang; Thomas L Chenevert; Larry Junck; Christina Tsien; Jason A Heth; Pia C Sundgren
Journal:  Acad Radiol       Date:  2016-02-23       Impact factor: 3.173

2.  The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma.

Authors:  Norbert Galldiks; Gabriele Stoffels; Christian Filss; Marion Rapp; Tobias Blau; Caroline Tscherpel; Garry Ceccon; Veronika Dunkl; Martin Weinzierl; Michael Stoffel; Michael Sabel; Gereon R Fink; Nadim J Shah; Karl-Josef Langen
Journal:  Neuro Oncol       Date:  2015-05-24       Impact factor: 12.300

Review 3.  Late effects of cancer treatment: consequences for long-term brain cancer survivors.

Authors:  Montse Alemany; Roser Velasco; Marta Simó; Jordi Bruna
Journal:  Neurooncol Pract       Date:  2020-07-16

Review 4.  Imaging findings in radiation therapy complications of the central nervous system.

Authors:  Tomonori Kanda; Yuichi Wakabayashi; Feibi Zeng; Yoshiko Ueno; Keitaro Sofue; Takaki Maeda; Munenobu Nogami; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2018-07-24       Impact factor: 2.374

Review 5.  Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies.

Authors:  Nishant Verma; Matthew C Cowperthwaite; Mark G Burnett; Mia K Markey
Journal:  Neuro Oncol       Date:  2013-01-16       Impact factor: 12.300

6.  Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.

Authors:  Francesco Cicone; Christian P Filss; Giuseppe Minniti; Camilla Rossi-Espagnet; Annalisa Papa; Claudia Scaringi; Norbert Galldiks; Alessandro Bozzao; N Jon Shah; Francesco Scopinaro; Karl-Josef Langen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-07       Impact factor: 9.236

7.  Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.

Authors:  Morad Nasseri; Seymur Gahramanov; Joao Prola Netto; Rongwei Fu; Leslie L Muldoon; Csanad Varallyay; Bronwyn E Hamilton; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2014-02-11       Impact factor: 12.300

8.  Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients.

Authors:  Vaios Hatzoglou; Gary A Ulaner; Zhigang Zhang; Kathryn Beal; Andrei I Holodny; Robert J Young
Journal:  Clin Imaging       Date:  2012-10-12       Impact factor: 1.605

9.  Pseudoprogression after proton beam irradiation for a choroid plexus carcinoma in pediatric patient: MRI and PET imaging patterns.

Authors:  Amine M Korchi; Valentina Garibotto; Marc Ansari; Laura Merlini
Journal:  Childs Nerv Syst       Date:  2012-11-15       Impact factor: 1.475

10.  Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model.

Authors:  Xiaohua Hong; Li Liu; Meiyun Wang; Kai Ding; Ying Fan; Bo Ma; Bachchu Lal; Betty Tyler; Antonella Mangraviti; Silun Wang; John Wong; John Laterra; Jinyuan Zhou
Journal:  Neuro Oncol       Date:  2013-12-22       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.